Major Advances in the Treatment of Cancer What does a Non-Oncologist need to know?
Journal Title: Sultan Qaboos University Medical Journal - Year 2008, Vol 8, Issue 2
Abstract
Te last few years have seen major advances in the management of cancers. Since it is not possible for the non-oncologist to keep abreast with the latest developments in the field of oncology, this review summarises the most significant advances in the area of treatment of various cancers over the past four years. In some areas, a paradigm shift has occurred setting new standards of care, for example, the use of targeted therapy (trastuzumab) in adjuvant treatment of breast cancer; the use of monoclonal antibodies (rituximab), with or without chemotherapy, in the treatment and maintenance of indolent lymphoma; the use of the tyrosine kinase inhibitor, imatinib, in the adjuvant setting in resected gastrointestinal stromal tumours. In other areas, new treatments have emerged, such as, the use of targeted therapies in hepatocellular carcinoma (sorafenib) and renal cell carcinoma (sunitinib, sorafenib, temsirolimus, bevacizumab). In some other cancers, the addition of targeted therapies has improved survival rates, for example, in colon cancer (bevacizumab, cetuximb, panitumumab), head and neck cancers (cetuximab), and pancreatic adenocarcinoma (erlotinib). In yet another group, new targeted therapies have emerged where resistance was previously observed with the existing targeted therapies, for example, breast cancer (lapatinib), chronic myeloid leukemia (dasatinib). Finally, the addition of chemotherapeutic agents has improved survival in some forms of cancer, for example, oxaliplatin in adjuvant treatment of colon cancer, temozolamide in glioblastoma multiforme, and adjuvant chemotherapy in non-small cell lung cancer. Te information summarized here may provide useful for the busy physician needing an update in the field of oncology.
Authors and Affiliations
Ikram A Burney| Department of Medicine, Sultan Qaboos University, Muscat, Oman, Mansour S Al-Moundhri| Department of Medicine, Sultan Qaboos University, Muscat, Oman
Keywords
Related Articles
- EP ID EP13794
- DOI -
- Views 307
- Downloads 13
Effects of an Adenotonsillectomy on the Cognitive and Behavioural Function of Children Who Snore: A naturalistic observational study
Objectives: This study aimed to evaluate cognitive and behavioural changes among 9–14-year-old Omani children with obstructive sleep apnoea (OSA) after an adenotonsillectomy (AT). Methods: This naturalistic observational...
Abortion and Ensoulment
Diabetes Care in Oman Obstacles and solutions
Diabetes has become one of the most challenging chronic diseases with its prevalence increasing in most countries worldwide. Te Arabian Gulf countries face a similar increasing prevalence of diabetes. Diabetes care req...
Atopy in Omani patients with asthma
Objectives: To determine the range of serum IgE in healthy subjects and in asthmatic patients in Oman and to assess the degree of atopy in the asthmatic patients. Method: Serum IgE and in vivo (the skin prick test) and...
Mitochondrial Oxygen Consumption by the Foreskin and its Fibroblast-rich Culture
Objectives: Tis study investigated the feasibility of using a phosphorescence oxygen analyser to measure cellular respiration (mitochondrial O2 consumption) in foreskin samples and their fbroblast-rich cultures. Method...